Abstract:Ru(II) complexes with weak ligand fields may undergo light‐induced ligand dissociation, and the resulted Ru(II) aqua complexes may bind with biomolecules such as DNA, showing potential as photoactivated chemotherapy (PACT) agents. However, Ru(II) complexes with efficient PACT activity are still rare. Some Ru(II) complexes exhibit efficient photoinduced ligand dissociation but poor cytotoxicity. It is speculated that the low nuclear accumulation levels may account for their low PACT efficacy. In order to confirm this hypothesis, the almost noncytotoxic [Ru(7‐OCH3‐dppz)(4‐OCH3‐py)4](PF6)2 (Ru1) is loaded on nucleus‐targeted C5N2 nanoparticles (NPs). Compared with the free Ru1, Ru1–C5N2 NPs exhibit significantly increased cellular uptake and nuclear accumulation. Therefore, Ru1–C5N2 NPs show efficient PACT activity toward various cancer cell lines (including cisplatin‐resistant one) with half maximal inhibitory concentration (IC50) values of 0.18 × 10−6–0.29 × 10−6 m and phototoxicity index (IC50dark/IC50light) values above 137 under both normoxic and hypoxic conditions. Moreover, Ru1–C5N2 NPs also exhibit efficient PACT activity toward cisplatin‐resistant 3D multicellular tumor spheroids upon two‐photon irradiation (800 nm). The same strategy is also feasible to greatly improve the PACT activity of [Ru(7‐OCH3‐dppz)(py)4]2+, which itself only has a medium effect. The results may provide new sights for developing efficient Ru(II) PACT agents. The almost noncytotoxic [Ru(7‐OCH3‐dppz)(4‐OCH3‐py)4]2+ can be converted into a highly efficient photoactivated chemotherapy (PACT) agent by loading on the nucleus‐targeted C5N2 nanoparticles. Increasing the nuclear accumulation levels of Ru(II) complexes with photolabile ligands greatly improves the PACT activity. The results may provide new sights for developing novel and efficient Ru(II) PACT agents.

Protein Nanocages for Delivery and Release of Luminescent Ruthenium(II) Polypyridyl Complexes.

A Dual-Fluorescent Nano-Carrier for Delivering Photoactive Ruthenium Polypyridyl Complexes

Preparation, Purification, and Characterization of Binuclear Ruthenium(II) Complexes: Bridging Ligands Based on Diazafluorenes

Diatom-like silica–protein nanocomposites for sustained drug delivery of ruthenium polypyridyl complexes

Photoexpulsion of Surface-Grafted Ruthenium Complexes and Subsequent Release of Cytotoxic Cargos to Cancer Cells from Mesoporous Silica Nanoparticles.

Enhanced Stable Luminescence and Photochemical Properties of Ruthenium Complex/zirconium Phosphate Hybrid Assemblies.

Converting an Almost Noncytotoxic Ru(II) Complex with Photolabile Ligands into a Highly Efficient PACT Agent

Photorelease of a metal-binding pharmacophore from a Ru(II) polypyridine complex

Luminescent iridium(III) complexes as novel protein staining agents.

New ruthenium polypyridyl complexes functionalized with fluorine atom or furan: Synthesis, DNA-binding, cytotoxicity and antitumor mechanism studies

Increasing the cytotoxicity of Ru(II) polypyridyl complexes by tuning the electron donating ability of 1,10-phenanthroline ligands

Unusual enantioselective cytoplasm-to-nucleus translocation and photosensitization of the chiral Ru(II) cationic complex via simple ion-pairing with lipophilic weak acid counter-anions

Ferritin nanocages to encapsulate and deliver photosensitizers for efficient photodynamic therapy against cancer.

Ru(ii) polypyridyl complex-incorporated and folate-conjugated vehicle for cancer cell imaging and photoinduced inactivation.

Development of Ruthenium Nanophotocages with Red or Near‐Infrared Light‐Responsiveness

Fluorescent supramolecular polypseudorotaxane architectures with Ru(II)/tri(bipyridine) centers as multifunctional DNA reagents

Ruthenium-containing supramolecular nanoparticles based on bipyridine-modified cyclodextrin and adamantyl PEI with DNA condensation properties

pH luminescence switching, dihydrogen phosphate sensing, and cellular uptake of a heterobimetallic ruthenium(II)-rhenium(I) complex.

Silica Nanospheres Entrapped with Ultra-Small Luminescent Crystals for Protein Delivery

Efficient NIR Electrochemiluminescent Dyes Based on Ruthenium(ii) Complexes Containing an N-heterocyclic Carbene Ligand.

Ruthenium(II) Polypyridyl Complexes: Cellular Uptake, Cell Image and Apoptosis of HeLa Cancer Cells Induced by Double Targets